A Digimed Oncology PharmacoTherapy Registry

Status unconfirmed

Conditions studied: Colon Cancer, Breast Cancer, Rectal Cancer

In brief

DigiMeds™ are medications with FDA-approved ingestible sensors (IS), a wearable sensor patch (patch), and a mobile app, which records time-stamped medication type and dose alongside biometric activity. The aim of this registry is to collect and analyze data on the use of DigiMeds™ and a digital feedback system on medication adherence, patient-provider communication, and data-driven optimization of therapy for cancer patients.

Key facts

Study ID

NCT04088955

Run by

Proteus Digital Health, Inc.

People needed

500

Starts

2019-09-06

Expected to finish

2022-03-01

Last updated by the study team

2020-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age ≥ 18
• Prescribed treatment with DigiMeds™
• Have an Android or iOS-enabled device (e.g., iPhone, iPad, Samsung) or be willing to use a Proteus issued iOS device
• Signed consent form

You may not qualify if…

• Receiving palliative or hospice care services (i.e., proxy for <12 months life expectancy)
• Not proficient in the English language
• Have impaired cognitive ability
• For women: current pregnancy
• Have skin sensitivity to adhesives or active/chronic dermatitis

Where it is running

• Carolina Blood and Cancer Care — Rock Hill, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.